FQ 1 Pill - orange capsule/oblong, 24mm
Pill with imprint FQ 1 is Orange, Capsule/Oblong and has been identified as Acetazolamide Extended-Release 500 mg. It is supplied by Accord Healthcare Inc.
Acetazolamide is used in the treatment of Glaucoma; Hydrocephalus; Edema; Epilepsy; Mountain Sickness / Altitude Sickness and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for FQ 1
Acetazolamide Extended-Release
- Imprint
- FQ 1
- Strength
- 500 mg
- Color
- Orange
- Size
- 24.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants, Carbonic anhydrase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Accord Healthcare Inc.
- National Drug Code (NDC)
- 16729-0331
More about acetazolamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (188)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
- Acetazolamide drug information
- Acetazolamide (Intravenous) (Advanced Reading)
- Acetazolamide (Oral) (Advanced Reading)
- Acetazolamide Tablets
- Acetazolamide Sustained-Release Capsules
- Acetazolamide Injection Solution
Other brands
Professional resources
- Acetazolamide monograph
- Acetazolamide (FDA)
- Acetazolamide Capsules (FDA)
- Acetazolamide Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
